GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Biosensors Inc (ASX:UBI) » Definitions » Long-Term Capital Lease Obligation

Universal Biosensors (ASX:UBI) Long-Term Capital Lease Obligation : A$3.23 Mil (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Universal Biosensors Long-Term Capital Lease Obligation?

Universal Biosensors's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$3.23 Mil.

Universal Biosensors's quarterly Long-Term Capital Lease Obligation declined from Jun. 2023 (A$3.72 Mil) to Sep. 2023 (A$3.53 Mil) and declined from Sep. 2023 (A$3.53 Mil) to Dec. 2023 (A$3.23 Mil).

Universal Biosensors's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (A$1.69 Mil) to Dec. 2022 (A$4.00 Mil) but then declined from Dec. 2022 (A$4.00 Mil) to Dec. 2023 (A$3.23 Mil).


Universal Biosensors Long-Term Capital Lease Obligation Historical Data

The historical data trend for Universal Biosensors's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Biosensors Long-Term Capital Lease Obligation Chart

Universal Biosensors Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 3.60 1.69 4.00 3.23

Universal Biosensors Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 3.84 3.72 3.53 3.23

Universal Biosensors  (ASX:UBI) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Universal Biosensors Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Universal Biosensors's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Biosensors (ASX:UBI) Business Description

Traded in Other Exchanges
N/A
Address
1 Corporate Avenue, Rowville, VIC, AUS, 3178
Universal Biosensors Inc is a developer of biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in its hand-held portable analysers for cost effective, effortless, and accurate detection of analytes of interest, within many industries including human health, animal health, environmental, and agriculture, enabling high speed, ease of use, reliability, accuracy at low cost.

Universal Biosensors (ASX:UBI) Headlines

No Headlines